Humoral and cellular immunologic repertoire in Alzheimer's disease.

Annals of the New York Academy of SciencesVolume 663, Issue 1 p. 349-356 Humoral and Cellular Immunologic Repertoire in Alzheimer's Disease L. AMADUCCI, L. AMADUCCI Department of Neurological and Psychiatric Sciences University of Florence Viale Morgagni 85 50134 Florence, ItalySearch for more papers by this authorM. FALCINI, M. FALCINI Department of Neurological and Psychiatric Sciences University of Florence Viale Morgagni 85 50134 Florence, ItalySearch for more papers by this authorA. LIPPI, A. LIPPI Department of Neurological and Psychiatric Sciences University of Florence Viale Morgagni 85 50134 Florence, ItalySearch for more papers by this author L. AMADUCCI, L. AMADUCCI Department of Neurological and Psychiatric Sciences University of Florence Viale Morgagni 85 50134 Florence, ItalySearch for more papers by this authorM. FALCINI, M. FALCINI Department of Neurological and Psychiatric Sciences University of Florence Viale Morgagni 85 50134 Florence, ItalySearch for more papers by this authorA. LIPPI, A. LIPPI Department of Neurological and Psychiatric Sciences University of Florence Viale Morgagni 85 50134 Florence, ItalySearch for more papers by this author First published: November 1992 https://doi.org/10.1111/j.1749-6632.1992.tb38678.xCitations: 6AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 Skullerud, K. 1985. Variations in the size of the human brain. Acta Neurol. Scand. Suppl. 102: 1–94. 2 Terry, R., R. Deteresa & L. Hansen. 1987. Neocortical cell counts in normal human adult aging. Ann. Neurol. 21: 530–539. 3 Khachaturian, Z. 1985. Diagnosis of Alzheimer's disease. Arch. Neurol. 42: 1097–1104. 4 Wilcok, G. K., M. M. Esiri, D. M. Bowen & C. C. Smith. 1982. Alzheimer's disease. Correlation of cortical choline acetyl transferase activity with the severity of dementia and histological abnormalities. J. Neurol. Sci. 57: 407–417. 5 Neary, D. 1990. Non Alzheimer's disease forms of cerebral atrophy. J. Neurol. Neurosurg. Psychiatry 53: 929–931. 6 Homer, A. C., M. Honavar, P. L. Lantos, I. R. Hastie, J. M. Kellett & P. H. Millard. 1988. Diagnosing dementia: Do we get it right Br. Med. J. 297: 894–896. 7 Heiling, C. W., D. S. Knopman, A. R. Mastri & W. Frey, Ii. 1985. Dementia without Alzheimer pathology. Neurology 35: 762–765. 8 Katzman, R., R. D. Terry, R. Deteresa, T. Brown, P. Davies, P. Fuld, X. Rembing & A. Peck. 1988. Clinical, pathological and neurochemical changes in dementia: A subgroup with preserved mental status and numerous neocortical plaques. Ann. Neurol. 23: 138–144. 9 Terry, R. D., E. Masliah, D. P. Salmon, N. Butters, R. Deteresa, R. Hill, L. A. Hansen & R. Katzman. 1991. Physical basis of cognitive alterations in Alzheimer's disease: Synapse loss is the mayor correlate of cognitive impairment. Ann. Neurol. 30: 572–580. 10 Van Duijn, C. M., D. Clayton, V. Chandra, L. Fratiglioni, A. B. Graves, A. Heyman, A. F. Jorm, E. Kokmen, K. Kondo, J. A. Mortimer, W. A. Rocca, S. L. Shalat, H. Soininen & A. Hofman, For The Eurodem Risk Factors Research Group. 1991. Familial aggregation of Alzheimer's disease and related disorders: A collaborative re-analysis of case-control studies. Int. J. Epidemiol. 20(Suppl. 2): S13–S20. 11 Rocca, W. A., C. M. Van Duijn, D. Clayton, V. Chandra, L. Fratiglioni, A. B. Graves, A. Heyman, A. F. Jorm, E. Kokmen, K. Kondo, J. A. Mortimer, S. L. Shalat, H. Soininen & A. Hofman, For The Eurodem Risk Factors Research Group. 1991. Maternal age and Alzheimer's disease: A collaborative re-analysis of case-control studies. Int. J. Epidemiol. 20(Suppl. 2): S21–S27. 12 St. George Hyslop, P. H., J. L. Hines, L. A. Farrer, R. Polonski & Other Members Of Fad Collaborative Study Group. 1990. Genetic linkage studies suggest that Alzheimer's disease is not a single homogeneous disorder. Nature 347: 194–197. 13 Murrell, J., M. Farlow, B. Ghetti & M. D. Benson. 1991. A mutation in the amyloid precursor protein associated with hereditary Alzheimer's disease. Science 254: 97–99. 14 Mortimer, J., C. M. Van Duijn, V. Chandra, L. Fratiglioni, A. B. Graves, A. Heyman, A. F. Jorm, E. Kokmen, K. Kondo, W. A. Rocca, S. L. Shalat, H. Soininen & A. Hofman, For The Eurodem Risk Factors Research Group. 1991. Head trauma as a risk factor for Alzheimer's disease: A collaborative reanalysis of case-control studies. Int. J. Epidemiol. 20(Suppl. 2): S28–S35. 15 Graves, A. B., E. White, T. D. Koepsell, B. V. Reiflen, G. Van Belle & E. B. Larson. 1990. The association between aluminum-containing products and Alzheimer's disease. J. Clin. Epidemiol. 43: 35–44. 16 Renvoize, E. B., I. O. Awad & M. H. Hambling. 1987. A sero-epidemiological study of conventional infectious agents in Alzheimer's disease. Age Ageing 16: 311–314. 17 Friedland, R. P., C. May & J. Dahlberg. 1990. The viral hypothesis of Alzheimer's disease. Absence of antibodies to lentiviruses. Arch. Neurol. 47: 177–178. 18 Manvelidis, E. E., J. M. De Figueiredo, J. M. Kim, W. W. Fritch & L. Manvelidis. 1988. Transmission studies from blood of Alzheimer's disease patients and healthy relatives. Proc. Natl. Acad. Sci. USA 85: 4898–4901. 19 Heston, L. L., A. R. Mastri, V. E. Anderson & J. White. 1981. Dementia of Alzheimer type: Clinical genetics, natural history, and associated conditions. Arch. Gen. Psychiatry. 38: 1085–1090. 20 Heyman, A., W. E. Wilkinson, J. A. Stafford, M. J. Helms, A. H. Sigmon & T. Weinberg. 1984. Alzheimer's disease: A study of epidemiological aspects. Ann. Neurol. 15: 335–341. 21 Amaducci, L. A., L. Fratiglioni, W. A. Rocca, C. Fieschi, P. Livrea, D. Pedona, L. Bracco, A. Lippi, C. Gandolfo, G. Bino, M. Prencipe, M. L. Bonatti, F. Girotti, F. Carella, B. Tavolato, S. Ferla, G. L. Lenzi, A. Carolei, A. Gambi, F. Grigoletto & B. S. Schoenberg. 1986. Risk factors for clinically diagnosed Alzheimer's disease: A case-control study of an Italian population. Neurology 36: 922–931. 22 Graves, A. B., E. White, T. Koepsell & B. Reifler. 1987. A case-control study of Alzheimer's disease. Am. J. Epidemiol. 126: 754. 23 Renvoize, E. B. 1984. An HLA and family study of Alzheimer's disease. Psychol. Med. 14: 515–520. 24 Clinton, J., M. W. Ambler & G. W. Roberts. 1991. Post-traumatic Alzheimer's disease: Preponderance of a single plaque type. Neuropathol. Appl. Neurobiol. 17: 69–74. 25 Mortimer, J. A., L. R. French, J. T. Hutton & L. M. Schuman. 1985. Head injury as a risk factor for Alzheimer's disease. Neurology 35: 264–267. 26 Nandy, K. 1972. Neuronal degeneration in aging and after experimental injury. Exp. Gerontol. 7: 303–311. 27 Ingram, C., K. Phegan & H. Blumenthal. 1974. Significance of an aging-linked neuron binding gamma globulin fraction of human sera. J. Gerontol. 29: 20–27. 28 Nandy, K. 1978. Brain reactive antibodies in aging and senile dementia. In Alzheimer's Disease-Senile Dementia and Related Disorders. R. Katzman, R. Terry & K. Bick, Eds.: 503–512. Raven Press. New York . 29 Nandy, K. 1981. Brain-reactive antibodies in aging non-human primates. Mech. Ageing Dev. 16: 141–146. 30 Fillit, H., V. N. Luine, B. Reisberg, B. Amador, B. Mcewen & J. Zabriskie. 1985. Studies of the specificity of antibrain antibodies in Alzheimer's disease. In Senile Dementia of the Alzheimer Type. J. Hutton & A. Kennedy, eds.: 307–318. Alan Liss. New York . 31 Mcrae-Deguerce, A., S. Booj, K. Haglid, L. Rosengren, J. E. Karlsson, I. Karlsson, A. Wallin, L. Svennerholm, C. G. Gotteries & A. Dahlstrom. 1987. Antiboies in CSF of some Alzheimer's patients recognize cholinergic neurons in the rodent central nervous system. Proc. Natl. Acad. Sci. USA 84: 9214–9218. 32 Lal, H., M. Bennett, D. Bennett, M. J. Foster & K. Nandy. 1986. Learning deficits occur in young mice following transfer of immunity from senescent mice. Life Sci. 39: 507–512. 33 Ingram, D. K., R. Weindruch, E. L. Spangler, J. R. Freeman & R. L. Walford. 1987. Dietary restriction benefits learning and motor performance of aged mice. J. Gerontol. 42: 78–81. 34 Mcgeer, P. L., H. Akiyama, S. Itagaki & E. G. Mcgeer. 1989. Immune system response in Alzheimer's disease. Can. J. Neurol. Sci. 16: 516–527. 35 Ishii, T., S. Haga & F. Kametani. 1988. Presence of immunoglobulins and complements in the amyloid plaques in the brain of patients with Alzheimer's disease. In Immunology and Alzheimer's Disease. A. Pouplard-Barthelaix, J. Emile & Y. Christen, Eds.: 17–9. Springer-Verlag. Berlin , Heidelberg . 36 Eikelenboom, P. & F. C. Stam. 1982. Immunoglobulins and complement factors in senile plaques. Acta Neuropathol. (Berl). 57: 239–242. 37 Pouplard-Barthelaix, A. 1988. Immunological markers and neuropathological lesions in Alzheimer's disease. In Immunology and Alzheimer's Disease. A. Pouplard-Barthelaix, J. Emile & Y. Christen, eds.: 7–16. Springer-Verlag. Berlin , Heidelberg . 38 Miyakawa, T., S. Katsuragi, K. Watanabe, A. Shimoji & Y. Ikeuchi. 1986. Ultrastructural studies of amyloid fibrils and senile plaques in human brain. Acta Neuropathol. 70: 202–208. 39 Glenner, G. G., C. W. Wong, V. Quaranta & E. D. Eanes. 1986. The amyloid deposits in Alzheimer's disease: Their nature and pathogenesis. App. Pathol. 83: 7908–7912. 40 Florian, A., F. Casammenti & G. Pepeu. 1987. Recovery of cortical acetylcholine output after ganglioside treatment in rats with lesion of nucleus basalis. Neurosci. Lett. 75: 313–316. 41 Chapman, J., S. Ben-Ami, E. Wertman & D. M. Michaelson. 1988. Antibodies to ganglioside GM1 in patients with Alzheimer's disease. Neurosci. Lett. 86: 235–240. 42 Emory, C. R., T. A. Ala & W. H. Frey. 1987. Ganglioside monoclonal antibody (A2B5) labels Alzheimer's neurofibrillary tangles. Neurology 37: 768–772. 43 Blennow, K., P. Davidsson, A. Wallin, P. Fredman, C. G. Gotteries. I. Karlsson, J. E. Mansson & L. Svennerholm. 1991. Gangliosides in cerebrospinal fluid in “probable Alzheimer's disease”. Arch. Neurol. 48: 1032–1035. 44 Chapel, H. M., M. M. Esiri & G. K. Wilcock. 1984. Immunoglobulin and other proteins in the cerebrospinal fluid of patients with Alzheimer's disease. J. Clin. Pathol. 37: 697–699. 45 Williams, A., N. Papadopulos & T. N. Chase. 1980. Demonstration of CSF gammaglobulin banding in presenile dementia. Neurology 30: 882–884. 46 Alafuzoff, L. R. Adolfsson, G. Bucht, E. Jellum, P. D. Metha & B. Winblad. 1986. Isoelectric focusing and two dimensional gel electrophoresis in plasma and cerebrospinal fluid from patients with dementia. Eur. Neurol. 25: 285–289. 47 Wikkelso, C., C. Blomstrand & P. Nordquist. 1981. Cerebrospinal fluid investigations in multi-infarct dementia and senile dementia. Acta Neurol. Scand. 64: 1–11. 48 Blennow, K., A. Wallin, P. Davidsson, P. Fredman, C. G. Gottfries & L. Svennfrholm. 1990. Intra-blood-brain-barrier synthesis of immunoglobulins in patients with dementia of the Alzheimer type. In Alzheimer Disease and Associated Disorders. Vol. 4: 79–86. Raven Press. New York . 49 Alafuzoff, I., R. Adolfsson, G. Bucht & B. Winblad. 1983. Albumin and immunoglobulin in plasma and cerebrospinal fluid, and blood-cerebrospinal fluid barrier function in patients with dementia of Alzheimer type and multi-infarct dementia. J. Neurol. Sci. 60: 465–472. 50 Blennow, K., A. Wallin, P. Fredman, I. Karlsson, C. G. Gottfries & L. Svennerholm. 1990. Blood-brain-barrier disturbance in patients with Alzheimer's disease is related to vascular factors. Acta Neurol. Scand. 81: 323–326. 51 Fillit, H. M., E. Kemeny, V. Luine, M. E. Weksler & J. B. Zabriskie. 1987. Antivascular antibodies in the sera of patients with senile dementia of the Alzheimer's type. J. Gerontol. 42: 180–184. 52 Chapman, J., O. Bachar, A. D. Korczyn, E. Wertman & D. M. Michaelson. 1986. Antibodies to cholinergic cell bodies in Alzheimer's disease. In Alzheimer's and Parkinson's Diseases: Strategies for Research and Development. Advances in Behavioral Biology. A. Fischer, I. Hanin & C. Lachman, eds. Vol. 29: 329–336. Plenum Press. New York . 53 Bradford, H. F., P. Foley, M. Docherty, H. Fillit, V. N. Luine, B. Mcewen, G. Bucht, B. Winblad & J. Hardy. 1989. Antibodies in serum of patients with Alzheimer's disease cause immunolysis of cholinergic nerve terminals from the rat cerebral cortex. Can. J. Neurol. Sci. 16: 528–534. 54 Kingsley, B. S., F. Gaskin & S. M. Fu. 1988. Human antibodies to neurofibrillary tangles and astrocytes in Alzheimer's disease. J. Neuroimmunol. 19: 89–99. 55 Monning, U., U. Schreiter-Gasser, C. Hilbich, D. Bunke, R. Prior, C. L. Masters & K. Beyreuther. 1991. Alzheimer amyloid β/A4 protein-reactive antibodies in human sera and CSF. In Alzheimer's Disease: Basic Mechanisms, Diagnosis and Therapeutic Strategies. K. Iqbal, D. R. McLachlan, B. Winblad & H. M. Wisniewski, eds. 71: 556–563. J. Wiley & Sons, Ltd. Chichester , England . 56 Yankner, B. A. 1989. Amyloid and Alzheimer's disease: Cause or effect Neurobiol. Aging 10: 470–471. 57 Yankner, B. A., L. R. Dawes, S. Fisher, L. Villa-Komaroff, M. L. Oster-Granite & R. L. Neve. 1989. Neurotoxicity of a fragment of the amyloid precursor associated with Alzheimer's disease. Science 245: 417–420. 58 Rogers, J. & E. J. Mufson. 1990. Demonstrating immune-related antigens in Alzheimer's disease brain tissue. Neurobiol. Aging 11: 477–479. 59 Rogers, J., J. Luber-Narod, S. D. Styren & W. H. Civin. 1988. Expression of immune system-associated antigens by cells of the human central nervous system: Relationship to the pathology of Alzheimer's disease. Neurobiol. Aging 9: 339–349. 60 Itagaki, S., P. L. Mcgeer, H. Akiyama, S. Zhu & D. Selkoe. 1989. Relationship of microglia and astrocytes to amyloid deposits of Alzheimer disease. J. Neuroimmunol. 24: 173–182. 61 Wisniewski, H. M., J. Wegiel, K. Wang, M. Kujawa & B. Lach. 1989. Ultrastructural studies of the cells forming amyloid fibers in classical plaques. Can. J. Neurol. Sci. 16: 535–542. 62 Mclachan, D. R. C. A. J. Dalton, T. P. A. Kruck, M. Y. Bell, W. L. Smith, W. Kalow & D. F. Andrews. 1991. Intramuscular desferrioxamine in patients with Alzheimer's disease. The Lancet 337: 1304–1308. 63 Fudenberg, H. H. & V. K. Singh. 1988. Immunodiagnosis and immunotherapy of patients with Alzheimer's syndrome. In Immunology and Alzheimer's Disease. A. Pouplard-Barthelaix, J. Emile & Y. Christen, eds.: 98–107. Springer-Verlag. Berlin , Heidelberg . Citing Literature Volume663, Issue1Aging and Cellular Defense MechanismsNovember 1992Pages 349-356 ReferencesRelatedInformation